Podcasts about ecmo

Learning Objectives:By the end of this series, listeners should be able to discuss:The physiologic rationale supporting the use of airway pressure release ventilation (APRV) in ARDS. The patient populations most likely to benefit from APRV.Key published evidence that informs our use of APRV in critical care.An expert approach to managing a patient with APRV.Next steps in research that will direct our understanding of the use of APRV in pediatric critical care.About our Guest: Dr. Palen Mallory is an assistant professor of pediatrics at Duke University and a pediatric intensivist at Duke Children's Hospital. She completed medical school at Virginia Commonwealth University, a pediatric residency at Emory University, and a critical care fellowship at Vanderbilt University. She is interested in respiratory care research, including ECMO, respiratory failure, and ARDS.Selected References:Mallory, P., & Cheifetz, I. (2020). A comprehensive review of the use and understanding of airway pressure release ventilation. Expert Review of Respiratory Medicine, 14(3), 307–315. https://doi.org/10.1080/17476348.2020.1708719Frawley, P. M., & Habashi, N. M. (2004). Airway pressure release ventilation and pediatrics: Theory and practice. Critical Care Nursing Clinics of North America, 16(3 SPEC. ISS.), 337–348. https://doi.org/10.1016/J.CCELL.2004.04.003Fredericks, A. S., Bunker, M. P., Gliga, L. A., Ebeling, C. G., Ringqvist, J. R. B., Heravi, H., Manley, J., Valladares, J., & Romito, B. T. (2020). Airway Pressure Release Ventilation: A Review of the Evidence, Theoretical Benefits, and Alternative Titration Strategies. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 14. https://doi.org/10.1177/1179548420903297APRV Guideline - EMCrit Project. (n.d.). Retrieved March 30, 2025, from https://emcrit.org/squirt/aprv/Andrews P, Shiber J, Madden M, Nieman GF, Camporota L, Habashi NM. Myths and Misconceptions of Airway Pressure Release Ventilation: Getting Past the Noise and on to the Signal. Front Physiol. 2022 Jul 25;13:928562. doi: 10.3389/fphys.2022.928562. PMID: 35957Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.

Learning Objectives:By the end of this series, listeners should be able to discuss:The physiologic rationale supporting the use of airway pressure release ventilation (APRV) in ARDS. The patient populations most likely to benefit from APRV.Key published evidence that informs our use of APRV in critical care.An expert approach to managing a patient with APRV.Next steps in research that will direct our understanding of the use of APRV in pediatric critical care.About our Guest: Dr. Palen Mallory is an assistant professor of pediatrics at Duke University and a pediatric intensivist at Duke Children's Hospital. She completed medical school at Virginia Commonwealth University, a pediatric residency at Emory University, and a critical care fellowship at Vanderbilt University. She is interested in respiratory care research, including ECMO, respiratory failure, and ARDS.Selected References:Mallory, P., & Cheifetz, I. (2020). A comprehensive review of the use and understanding of airway pressure release ventilation. Expert Review of Respiratory Medicine, 14(3), 307–315. https://doi.org/10.1080/17476348.2020.1708719Frawley, P. M., & Habashi, N. M. (2004). Airway pressure release ventilation and pediatrics: Theory and practice. Critical Care Nursing Clinics of North America, 16(3 SPEC. ISS.), 337–348. https://doi.org/10.1016/J.CCELL.2004.04.003Fredericks, A. S., Bunker, M. P., Gliga, L. A., Ebeling, C. G., Ringqvist, J. R. B., Heravi, H., Manley, J., Valladares, J., & Romito, B. T. (2020). Airway Pressure Release Ventilation: A Review of the Evidence, Theoretical Benefits, and Alternative Titration Strategies. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 14. https://doi.org/10.1177/1179548420903297APRV Guideline - EMCrit Project. (n.d.). Retrieved March 30, 2025, from https://emcrit.org/squirt/aprv/Andrews P, Shiber J, Madden M, Nieman GF, Camporota L, Habashi NM. Myths and Misconceptions of Airway Pressure Release Ventilation: Getting Past the Noise and on to the Signal. Front Physiol. 2022 Jul 25;13:928562. doi: 10.3389/fphys.2022.928562. PMID: 35957Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.

In this episode of the St Emlyn's Podcast, Iain Beardsell and Simon Carley revisit January's  blog posts and podcasts, covering several seminal studies relevant to emergency and pre-hospital care. Topics include the Sub 30 Feasibility Study on pre-hospital ECMO, comparisons of pre-hospital versus in-hospital emergency anaesthesia, variations in maintenance of pre-hospital anaesthesia in trauma patients, and the effectiveness of physician-led pre-hospital teams. They also discuss the economic implications of advanced pre-hospital interventions and highlight reviews from the London Trauma Conference. 00:00 Introduction and January Recap 01:58 Pre-Hospital ECPR Study: The Sub 30 Study 07:09 Emergency Anaesthesia: Pre-Hospital vs. Emergency Department 13:55 Maintenance of Pre-Hospital Anaesthesia: Variations in Practice 16:57 Physician-Led Pre-Hospital Teams: Do They Improve Outcomes? 22:12 Additional Insights and Upcoming Content

當金曲歌后徐佳瑩發現在 Uber Eats 上（應該）都點得到，居然狂點一波！雖然點不到白馬和失落沙洲，但香水、辣椒或其他吃的用的都點得到～快上 Uber Eats 想要的都點點看⮕ https://fstry.pse.is/7jpjda —— 以上為 KKBOX 與 Firstory Podcast 廣告 —— **面對美英即將敲定汽車關稅調降協議，日本首相石破茂 5 月 11 日在富士電視台節目中表態強硬，針對日美間的關稅談判，他明言日本政府「一直要求取消關稅」，並不會接受「10% 就滿足」的論調。石破茂強調，雖然美英協議可被視為模式參考，但日方追求的是實質性取消，而非象徵性調整。石破茂進一步表態，日本在對美談判中將堅守農業底線，明言「不會為了汽車而犧牲農業」。他指出，近期國內大米價格上漲，政府將視情況考慮增加進口作為穩定糧價的選項之一，但這並不意味著開放市場的單向讓步，而是整體大米政策需重新檢討，包含提升農戶收入與國內競爭力。 **日本前經濟產業大臣西村康稔睽違多年訪台，受訪談及最難忘行程，他秒答「足底按摩」，雖然痛得令人想尖叫，但真的能消除疲勞，遺珠則是未能如願嚐到台南著名牛肉湯，希望有機會帶家人再次來台旅遊。被問及本次訪台目的，西村康稔說明，他擔任新冠疫情應對大臣時，從台灣收到口罩、葉克膜（ECMO）、血氧機等支援，受到極大幫助；而他在經產大臣任期內推動台積電進駐熊本的招商工作，台灣也提供支援，想藉此行表達感謝之意，此行也是為了要強化供應鏈的韌性。 **日本前經濟安全保障擔當大臣高市早苗，持續推動經濟安全保障，加上首相石破茂支持率下降，近來聲勢看漲。夏季東京都議會和參議院選舉結果，將是日本能否出現女首相的觀察重點。身為日本前經濟安全保障擔當大臣，高市當然十分關注安保相關議題，在去年7月出版的《日本的經濟安全保障——守護國家國民的黃金法則》一書中，她從強化供應鏈韌性、選定特定重要物資、加強安全查核制度等各種角度，來喚起日本國民注意。在台灣，她也特別強調安保，尤其是經濟安保的重要性。 #寶島聯播網 #寶島全世界 #矢板明夫 #陳文甲 #石破茂 #高市早苗 #西村康稔 #萬國博覽會 #台灣館 ❤️歡迎訂閱、收看、收聽，按讚、分享 【版權屬寶島聯播網所有，未經授權，不得轉載、重製，有需求請來信告知】 小額贊助支持本節目： https://open.firstory.me/user/clw4248xv113d01wg7s4h2xnq 留言告訴我你對這一集的想法： https://open.firstory.me/user/clw4248xv113d01wg7s4h2xnq/comments Powered by Firstory Hosting

In this episode of the Winners Find A Way show, host Trent M. Clark sits down with Tino Dietrich, a German-born entrepreneur and COVID survivor, to explore how hitting rock bottom physically can ignite a new path toward purpose, clarity, and entrepreneurial rebirth. After being placed on ECMO during a severe battle with COVID-19, Tino faced a near-death experience that completely changed the trajectory of his life. He dropped 90 pounds, found joy and purpose in golf, and launched Snyders Golf USA—a thriving business born from his second chance. Now, Tino's on a mission to help others “unfog” their own lives through his upcoming book, Unfogged. If you've ever faced life's biggest challenges and wondered how to rebuild with purpose, honesty, and fire in your belly, this episode is your blueprint.

In this episode of Deep Cuts: Exploring Equity in Surgery, Dr. Carmelle Romain and Dr. Kylie Callier provide an overview of the field of pediatric surgery. We cover key aspects of pediatric surgery, from common pediatric conditions to the factors that attract surgeons to the subspecialty. We also examine which populations of children lack access to surgery, and the reasons behind these barriers.  Finally, we highlight what the University of Chicago is doing to improve access for children and parents in Chicago's South Side. Dr. Carmelle Romain is a pediatric surgeon and Assistant Professor in the Department of General Surgery. She attended medical school at Brown University and completed her residency and fellowship training at Vanderbilt University and Miami Children's Hospital. In addition to her clinical practice, Dr. Romain is an active researcher examining how telehealth can expand access for pediatric patients.Dr. Kylie Callier is a 3rd-year surgery resident at UChicago Medicine and a fellow at the Maclean Center for Clinical Medical Ethics. She is an aspiring pediatric surgeon and attended medical school at Texas Tech University. Her research interests include pediatric trauma and pediatric ECMO, a life-supporting treatment for critically ill children with heart and/or lung failure. Deep Cuts: Exploring Equity in Surgery comes to you from the Department of Surgery at the University of Chicago, which is located on Ojibwe, Odawa and Potawatomi land.Our executive producer is Tony Liu. Our senior producers are Alia Abiad, Caroline Montag, and Chuka Onuh. Our production team includes Megan Teramoto, Ria Sood, Ishaan Kumar, and Daniel Correa Buccio. Our senior editor and production coordinator is Nihar Rama. Our editorial team also includes Beryl Zhou. The intro song you hear at the beginning of our show is “Love, Money Part 2” from Chicago's own Sen Morimoto off of Sooper Records. Our cover art is from Leia Chen.A special thanks this week to Dr. Jeffrey Matthews — for his leadership, vision, and commitment to caring for the most vulnerable in our communities. Let us know — what have you most enjoyed about our podcast. Where do you see room for improvement? You can reach out to us on Instagram @deepcutssurgery. Find out more about our work at deepcuts.surgery.uchicago.edu.

In this episode, Dr. Sergio Zanotti focuses on the nuances of mechanical ventilation in patients with severe asthma. Previously, he explored the medical management of acute asthma exacerbations. Today, he takes a deeper dive into ventilatory strategies tailored to this high-risk population. He's joined by Dr. Emily Damuth, a dual-trained emergency medicine and critical care physician. Dr. Damuth is an Assistant Professor of Medicine and Emergency Medicine at Cooper Medical School of Rowan University and practices clinically in both the Emergency Department and Intensive Care Unit at Cooper University Hospital in Camden, New Jersey. She is also an Assistant Program Director for the Critical Care Medicine Fellowship and is actively involved in the ECMO program. A passionate educator, she teaches mechanical ventilation through lectures and simulation and has received multiple teaching awards for her contributions to medical education. Additional resources: Links: Management of Life-Threatening Asthma. O. Garner, et al. CHEST 2022; https://pubmed.ncbi.nlm.nih.gov/35218742/ Extracorporeal Membrane Oxygenation for Refractory Asthma Exacerbations With Respiratory Failure. J. Zakrajsek, et al. CHEST 2023: https://pubmed.ncbi.nlm.nih.gov/36191634/ Ventilator Graphics and Respiratory Mechanics in the Patient With Obstructive Lung Disease. R. Dhand. Respiratory Care 2005: https://pubmed.ncbi.nlm.nih.gov/15691394/ Books mentioned in this episode: Seabiscuit: An American Legend. By Laura Hillenbrand: https://bit.ly/3EY24pJ Pisto: The Life of Pete Maravich. By Mark Kriegel: https://bit.ly/3GIarq6 Good Inside: A Practical Guide to Resilient Parenting Prioritizing Connection Over Correction. By Becky Kennedy: https://bit.ly/4iSTnes

Send us a textToday we dive into the life-saving (and often intimidating!) technology known as ECMO. Written by: Dr. Pavan Malhi (Internal Medicine Resident)Reviewed by: Dr. Liang Chen (General Internist & Critical Care Medicine Fellow) & Dr. Jed Lipes (Intensivist, General Internist)Support the show

In this month's episode of The Atrium, host Dr. Alice Copperwheat speaks with Dr. Jose Fernandes from the Department of Clinical Perfusion at Royal Papworth Hospital, Cambridge, UK, about extracorporeal membrane oxygenation (ECMO). Chapters 00:00 Introduction 01:47 History 04:46 Basics 09:58 Circuit 14:09 Cannulation 22:44 Indications for Use 28:14 VV ECMO 32:18 VA ECMO 36:44 Monitoring 42:31 Complications 47:03 ECMO CPR 49:17 Trainee Tips 50:57 Guest Advice They discuss cannulation, general indications and contraindications, venovenous (VV) ECMO, venoarterial (VA) ECMO, peripheral VA ECMO, and central VA ECMO. They also explore monitoring, cardiac function monitoring in VA ECMO, complications, ECMO cardiopulmonary resuscitation (CPR), and important tips for trainees.   The Atrium is a monthly podcast presenting clinical and career-focused topics for residents and early career professionals across all cardiothoracic surgery subspecialties. Watch for next month's one-year anniversary episode with a very special guest.   Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

In this episode, Dr. Rahul Damania, Dr. Pradip Kamat, and Dr. Monica Gray dive into a critical case involving a five-week-old baby facing acute respiratory failure due to pertussis. They chat about how this condition shows up, how it's diagnosed, and the best ways to manage it, especially considering the serious complications it can cause in infants, like pulmonary hypertension and the potential need for ECMO. The conversation underscores the importance of catching it early and providing supportive care, while also highlighting how crucial vaccination is in preventing pertussis. Tune in to learn how severe this disease can be and why staying alert in pediatric care is so important.Show Highlights:Clinical case of a five-week-old infant with acute respiratory failure and pertussis diagnosisEpidemiology and public health impact of pertussis, including vaccination rates and outbreak patternsPathophysiology of pertussis and its effects on respiratory health, particularly in infantsClinical presentation of pertussis, including stages of the disease and atypical symptoms in infantsDiagnostic approaches for pertussis, including laboratory findings and PCR testingManagement strategies for severe pertussis, including supportive care and antibiotic therapyPotential complications associated with pertussis, especially in young infantsDifferential diagnosis considerations for pertussis and distinguishing features from other infectionsImportance of vaccination in preventing pertussis and reducing morbidity and mortalityECMO as a treatment option for severe cases and its associated challenges, and outcomesWe welcome you to share your feedback, subscribe & place a review on our podcast! Please visit our website picudoconcall.org.References:Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter and Rogers texbook of Pediatric intensive care -both do not have any Pertussis mentioned in their index.Rowlands HE, Goldman AP, Harrington K, Karimova A, Brierley J, Cross N, Skellett S, Peters MJ. Impact of rapid leukodepletion on the outcome of severe clinical pertussis in young infants. Pediatrics. 2010 Oct;126(4):e816-27. doi: 10.1542/peds.2009-2860. Epub 2010 Sep 6. PMID: 20819895.Lauria AM, Zabbo CP. Pertussis. [Updated 2022 Oct 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519008/Berger JT, Carcillo JA, Shanley TP, Wessel DL, Clark A, Holubkov R, Meert KL, Newth CJ, Berg RA, Heidemann S, Harrison R, Pollack M, Dalton H, Harvill E, Karanikas A, Liu T, Burr JS, Doctor A, Dean JM, Jenkins TL, Nicholson CE; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Collaborative Pediatric Critical Care Research Network (CPCCRN). Critical pertussis illness in children: a multicenter prospective cohort study. Pediatr Crit Care Med. 2013 May;14(4):356-65. doi: 10.1097/PCC.0b013e31828a70fe. PMID: 23548960; PMCID: PMC3885763.Cousin, V.L., Caula, C., Vignot, J. et al. Pertussis infection in critically ill infants: meta-analysis and validation of a mortality score. Crit Care 29, 71 (2025). https://doi.org/10.1186/s13054-025-05300-2Domico M, Ridout D, MacLaren G, Barbaro R, Annich G, Schlapbach LJ, Brown KL. Extracorporeal Membrane Oxygenation for Pertussis: Predictors of Outcome Including Pulmonary Hypertension and Leukodepletion. Pediatr Crit Care Med. 2018 Mar;19(3):254-261. doi:...

In this episode, Dr. Valentin Fuster dives into the complex and high-stakes world of cardiogenic shock, spotlighting new clinical trials, expert consensus guidance, and cutting-edge insights from machine learning. From evaluating the impact of intra-aortic balloon pumps to rethinking mechanical support strategies, the episode delivers a powerful update on one of cardiology's most urgent challenges.

The ACGME is planning to add a year to Emergency Medicine residency training. Emergency medicine stands at a crossroads.  Should EM residency training be standardized at four years?On the show today are three Emergency Medicine residency program directors.  Together, we discuss the history of 3- vs. 4-year EM programs, the evolving demands of emergency medicine, and what a fourth year could mean for future physicians, the healthcare system, and the patients we serve. From rural workforce implications to the shifting landscape of ultrasound, addiction medicine, and EMS, we discuss the nuances of a moment of transformation in medical training.We close the episode with a reading of Roald Dahl's powerful and heartbreaking essay on vaccine-preventable illness, and a sobering look at the 2025 resurgence of measles and pertussis.Sameer Desai is the program director for the EM residency at UK and was previously the associate and an assistant EM residency program director.Chris Belcher is the associate program director for UK EM.  After residency, he spent 4 years in active duty Air Force service in San Antonio working with Air Force and Army EM residents and flying ICU and ECMO patients around the world.Blake Davidson is an assistant program director for UK EM.  After residency, he spent a year completing an EMS fellowship in Alabama. He also serves as the Medical Director of UK Transport.***********If you have any feedback, show/interview recommendations, or want to collaborate on the show, please reach out!Email: Tama.TheMDM@gmail.comInstagram: TheMDM.podcastTwitter: theMDMpodcast***********Host: Tama Thé | Pediatric Emergency MedicineProducer: Melissa Puffenbarger | Pediatric Emergency MedicineCommunications Director: Katrianna Urrea | MD CandidateMusic: Spencer Brown

It's well known that many of the problems we encounter on a daily basis in medicine are related to ineffective communication. When caring for the critically ill, it's vital that such lapses in communication are minimized. Join us along with Genae Christensen- a current MS-2, active critical care flight nurse and prior ECMO program coordinator as we delve into some important communication pitfalls and pearls. We will cover topics such as the authority gradient and how to navigate that, where misunderstandings may stem from, and how using structured communication systems may help you stay out of trouble. Give us a listen, let us know YOUR thoughts, share the show with your friends, and leave us a review! Hosted on Acast. See acast.com/privacy for more information.

In this episode, Dr. Kristen Nordenholz breaks down some of the causes and differential for right heart failure in EM. This ties in with the prior podcast from CoACEP with Dr. Tems talking about the indications for ECMO.

In this month's episode of The Atrium, host Dr. Alice Copperwheat speaks with Dr. Thomas D'Amico about VATS lobectomy. Chapters 00:00 Introduction 01:47 Background 04:11 Indications 04:51 Preoperative Assessment 07:12 Setup 08:21 Patient Positioning 11:26 Basics 13:36 D'Amico's Port Placement 16:46 Uniportal 22:03 Steps 22:44 Anterior-Posterior Order 25:45 Anatomy 26:45 Instruments 30:54 Pleural Dissection 31:33 Inferior Pulmonary Ligament 31:39 Pulmonary Vein 32:01 Artery/Bronchus Dissection 33:38 Nodal Resection 36:25 Tips & Tricks 38:48 Specimen Removal 39:10 Closure 40:02 Postoperative Care 45:01 Outcomes 45:31 CT Surgery Training Advice They discuss the set-up, patient positioning, port placement, dissection of hilar structures, tips and tricks, and more. They also discuss preoperative assessment, nodal resection, specimen removal, closure, and outcomes.   The Atrium is a monthly podcast presenting clinical and career-focused topics for residents and early career professionals across all cardiothoracic surgery subspecialties. Watch for next month's episode on ECMO.   Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Following the discussion on ECLS in AMI and cardiogenic shock, we go on to discuss eCPR for cardiac arrest specifically. This episode was recorded live at the Critical Care Canada Forum 2024 as part of our special series on cardiac intensive care. Our guest is Dr. Darryl Abrams, Associate Medical Director and Director of Research for the Medical ECMO Program at New York-Presbyterian/Columbia University. Dr. Abrams joins us for an in-depth discussion on the current state and future direction of extracorporeal cardiopulmonary resuscitation, or eCPR.We dive into the complex world of eCPR in refractory cardiac arrest, starting with a breakdown of the three landmark trials that have shaped the field: the ARREST trial, the Prague OHCA trial, and the INCEPTION trial. Each study offers a unique perspective, from the dramatic early findings of ARREST to the pragmatic design of Prague OHCA and the sobering multicenter outcomes of INCEPTION. A major theme throughout the episode is the role of system design. Dr. Abrams emphasizes the importance of minimizing low-flow time, rapid cannulation, and consistent team expertise—factors that can make or break the success of eCPR. We also explore the ethical and practical considerations that come with rolling out such a resource-intensive intervention, including the balance between innovation and equity. Is it fair that access to eCPR may depend on geography or institutional resources? And how do we make meaningful improvements in survival when only a few centers can offer this advanced care?The episode closes with a practical lens: how should clinicians approach building an ECMO program? What are the essential pieces that need to be in place before considering eCPR? And how do you select patients in a way that balances risk, benefit, and system capacity?Chapters:Introduction and guest welcomeSetting the scene: What is eCPR and why now?The ARREST trial: Small study, big impactThe Prague OHCA trial: Early randomization, broader populationThe INCEPTION trial: Multicenter reality and negative resultsComparing the evidence: Why do outcomes differ?Low-flow time and speed of cannulationThe role of meta-analyses and what they do (and don't) tell usOpportunity cost: What are we giving up to fund eCPR?Duration of support: How long is too long?Will there be another trial? Challenges of equipoiseBuilding a responsible eCPR programPatient selection: Who qualifies and why?Cannulation techniques and adjunct devicesSystem design: U.S. vs. Canada vs. U.K.Ethical concerns and access inequitiesGuidelines and final takeaways

Podcast summary of articles from the February 2025 edition of the Journal of Emergency Medicine from the American Academy of Emergency Medicine.  Topics include ECPR, supraglottic airway devices, environmental factors in out of hospital cardiac arrest, pediatric admissions, Bechet's disease, and auricular hematomas.  Guest speaker is Dr. John Bennison.

In this World Shared Practice Forum Podcast, Dr. Graeme MacLaren shares his expert insight on the outcomes of central versus peripheral cannulation techniques for Extracorporeal Membrane Oxygenation (ECMO) in pediatric patients with refractory septic shock as published in the February issue of Pediatric Critical Care Medicine. The discussion focuses on the implications of ECMO modality choices, the conditions affecting cannulation strategy, and how institutional resources can impact patient outcomes. LEARNING OBJECTIVES - Differentiate between central and peripheral venoarterial ECMO strategies in pediatric septic shock - Analyze key papers in the literature to provide context for decision-making around ECMO deployment in refractory septic shock - Identify factors influencing the success and outcome of ECMO in refractory pediatric septic shock cases - Apply considerations for patient selection and institutional resource availability in ECMO planning AUTHORS Graeme MacLaren, MBBS, MSc, FRACP, FCICM, FCCM, FELSO Director of Cardiothoracic Intensive Care, National University Hospital, Singapore Clinical Director of ECMO, National University Heart Centre, Singapore Adjunct Professor, Department of Surgery, National University of Singapore Past President, Extracorporeal Life Support Organization Jeffery Burns, MD, MPH Emeritus Chief Division of Critical Care Medicine Department of Anesthesiology, Critical Care and Pain Medicine Boston Children's Hospital Professor of Anesthesia Harvard Medical School DATE Initial publication date: March 24, 2025. ARTICLES REFERENCED 1) MacLaren, Graeme MBBS, MSc, FELSO, FCCM. Cannulation Strategies for Extracorporeal Membrane Oxygenation in Children With Refractory Septic Shock. Pediatric Critical Care Medicine ():10.1097/PCC.0000000000003707, February 10, 2025. | DOI: 10.1097/PCC.0000000000003707 2) Totapally A, Stark R, Danko M, et al. Central or Peripheral Venoarterial Extracorporeal Membrane Oxygenation for Pediatric Sepsis: Outcomes Comparison in the Extracorporeal Life Support Organization Dataset, 2000-2021. Pediatr Crit Care Med. Published online January 23, 2025. doi:10.1097/PCC.0000000000003692 3) Schlapbach LJ, Chiletti R, Straney L, et al. Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis-a binational multicenter cohort study. Crit Care. 2019;23(1):429. Published 2019 Dec 30. doi:10.1186/s13054-019-2685-1 4) Bréchot N, Hajage D, Kimmoun A, et al. Venoarterial extracorporeal membrane oxygenation to rescue sepsis-induced cardiogenic shock: a retrospective, multicentre, international cohort study. Lancet. 2020;396(10250):545-552. doi:10.1016/S0140-6736(20)30733-9 TRANSCRIPT https://cdn.bfldr.com/D6LGWP8S/at/84gbxthfmhvp7v9fsnjb87mh/0320425_WSP_MacLaren_Transcript.pdf Please visit: http://www.openpediatrics.org OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children's Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open-access thus at no expense to the user. CITATION MacLaren G, Burns JP. Pediatric ECMO Cannulation Strategies in Refractory Septic Shock. 03/2025. OPENPediatrics. https://soundcloud.com/openpediatrics/pediatric-ecmo-cannulation-strategies-in-refractory-septic-shock-by-g-maclaren-openpediatrics.

In this episode of 3 Pie Squared - ABA Business Leaders, we welcome Melanie Thurston, a critical care nurse, author, and dedicated mother to a child with autism. Melanie shares her personal journey navigating the challenges of raising a child with autism, balancing professional life, and building strong caregiver relationships. She discusses the importance of supporting parents during the ABA intake process, reducing barriers for caregivers, and fostering collaboration between ABA providers and families. Melanie also touches on critical topics such as the impact on siblings, transitioning into adulthood, and the emotional journey parents face. Her heartfelt insights provide invaluable lessons for ABA business owners, clinicians, and caregivers striving to create meaningful, supportive relationships. About Our Guest: Melanie Thurston is a critical care nurse specializing in cardiovascular intensive care and ECMO life support. She is also an author, sharing her experiences as a parent of a child with autism to inspire and support other families navigating similar journeys. Her book, Mom, I'm Mater: My Life as an Autism Mom, provides a raw and heartfelt account of life as a special needs parent. Learn more about Melanie and her work at booksbymelaniethurston.com. Resources and Support:

In this episode, recorded live at the Critical Care Canada Forum in Toronto, we dive into extracorporeal life support (ECLS) in cardiogenic shock, with Dr Sean van Diepen. He is an Associate Professor at the University of Alberta, Co-Director of the CCU at the Mazankowski Alberta Heart Institute, and a leading voice in cardiac critical care. Join us as we explore the evolving landscape of mechanical circulatory support, the latest evidence from the DANGER and ECLS-SHOCK trials, and the complexities of patient selection. Key Topics Covered:1. The Evolution of ECLS in Cardiogenic Shock • The 25-year gap since the last positive cardiogenic shock trial. • How mechanical circulatory support expanded despite limited evidence.2. The DANGER Trial – Impella in AMI-Associated Cardiogenic Shock • Mechanism and function of the Impella device. • Trial results: 20% mortality reduction at 180 days. • Complications: Limb ischemia, hemolysis, and high costs. • Real-world application: Who actually qualifies?3. ECLS-SHOCK Trial – ECMO for Cardiogenic Shock • A "negative" trial, but a crucial wake-up call. • No mortality benefit but significantly higher complication rates. • Controversies: Inclusion of cardiac arrest patients and transition to destination therapy. • Future directions: Can patient selection improve outcomes?4. ECPR – Extracorporeal Support in Refractory Cardiac Arrest • Review of the ARREST, PRAGUE, and INCEPTION trials. • Why the evidence remains unclear and institution-dependent. • The role of high-volume ECMO centers and standardized pathways.5. The Future of ECLS – Cost, Ethics, and Decision-Making • How should institutions decide who gets ECMO? • The role of cardiogenic shock teams. • Could AI play a role in decision-making? • The challenge of resource allocation in a single-payer system.Key Takeaways:✅ Impella shows promise in carefully selected AMI shock patients but is costly and high-risk.✅ ECMO for cardiogenic shock remains controversial—patient selection is key.✅ ECPR is promising but needs further trials and structured implementation.✅ Cardiogenic shock management should be a team decision, not an individual one.

In this episode of PICU DOC on Call, Dr. Rahul Damania and Dr. Pradip Kamat chat about a challenging case involving a 15-year-old girl dealing with acute myocarditis and worsening respiratory failure. They explore the intricate dance between the heart and lungs, especially how positive pressure ventilation can affect heart function. They cover important topics like cardiac output, preload, and afterload, and discuss the delicate balance needed to manage myocarditis effectively. The episode offers practical tips for optimizing care for critically ill children, underscoring the importance of personalized treatment plans and teamwork in pediatric critical care. Tune in!Show Highlights:Clinical case of a 15-year-old girl with acute myocarditis and respiratory failureImportance of understanding cardiopulmonary interactions in pediatric critical careEffects of positive pressure ventilation on cardiac functionKey concepts of cardiac output, preload, and afterload in the context of myocarditisChallenges of managing hemodynamic instability in critically ill pediatric patientsDifferences between spontaneous breathing and positive pressure ventilationStrategies for optimizing preload and fluid management in myocarditis patientsTailoring ventilatory support and transitioning to invasive mechanical ventilationMonitoring for arrhythmias and managing myocardial function with inotropic supportImportance of frequent assessments and collaboration with cardiac ICU teams for patient careManagement StrategiesOptimizing Preload:Volume depletion is common in patients with hypotension and tachycardia. A careful fluid challenge is important to restore circulatory volume, but fluid overload should be avoided, especially with impaired left ventricular function.Tailoring Ventilatory Support:Adjust BiPAP settings to improve oxygenation without overloading the heart with excessive positive pressures.Use the optimal level of PEEP to recruit alveoli while maintaining adequate venous return to the heart.Supporting Myocardial Function:Inotropic support (e.g., milrinone) may be necessary to improve myocardial contractility. Milrinone also provides vasodilation, which can reduce afterload but must be used cautiously due to its potential to lower blood pressure.Frequent Reassessments:Bedside echocardiography and regular monitoring of biomarkers (lactate, BNP) and clinical status are essential for ongoing evaluation.In severe cases, advanced therapies like ECMO may be required if the patient's hemodynamic status continues to deteriorate.

LEXINGTON, Ky. (March 5, 2025) — It's hard to believe it's been five years since the COVID-19 pandemic officially arrived in the Commonwealth – but on Friday, March 6, 2020, Gov. Andy Beshear confirmed the state's first COVID-19-positive patient and declared a state of emergency in Kentucky. And that first case was tested and diagnosed right here at the University of Kentucky Albert B. Chandler Hospital. That day began a grueling, years-long grind for medical professionals across the state, the country, and the world. Hospital systems struggled to keep up with surges of severely ill patients coming through their doors. Shortages of personal protective equipment, ventilators, ECMO machines, inpatient beds, and even health care providers themselves led to a type of global health crisis not seen in more than a century.   In today's episode of Behind the Blue, you'll hear from eight longtime employees from the medical side of UK's campus, ranging from administrators to frontline health care providers to researchers. We asked them to reflect on those scary, early days of the pandemic, how it impacted their professional and personal lives, and some of the lessons learned from living through such a significant moment in history. Let's meet our guests for this oral history of the COVID-19 pandemic at UK and in the Commonwealth.   Jenn Alonso has been at UK HealthCare for 13 years and has worked in the medicine intensive care unit (MICU) as a registered nurse since 2014. As a MICU nurse, she works alongside a team of physicians, nurses, therapists and other providers to take care of some of the most critically ill patients who come to UK HealthCare. Alonso was working in the MICU the day UK's first COVID-19 patient was admitted and was directly involved in frontline care for the sickest COVID-19 patients day in and day out.   Kim Blanton, D.N.P., is the chief nursing officer for UK Albert B. Chandler Hospital. Blanton began her nursing career at UK in 1998 in the neuro-trauma ICU and worked her way up through several nursing positions, including rapid response nursing, working as a division charge nurse and managing the cardiovascular stepdown unit. After briefly leaving UK to help create and run an ICU at a local rural hospital, she returned in 2011 as a hospital operations administrator before becoming the UK HealthCare enterprise director for Infection Prevention and Control (IPAC) and Quality and Safety. Blanton was serving in her IPAC role when the COVID-19 pandemic began and was instrumental in UK's COVID-19 response: She helped bring home UK students from abroad, called COVID-19 patients to help them navigate their care and quarantine, developed plans and processes for patient surges and PPE needs, and much more.   Kevin Hatton, M.D., Ph.D., is the chief medical officer for UK Albert B. Chandler Hospital. An anesthesiologist by training, he earned both his medical degree and doctorate of philosophydegree from UK. Including his time in residency, Dr. Hatton has worked at UK HealthCare for 21 years, serving in a variety of leadership roles in anesthesiology in critical care medicineprimarily for neurology and cardiovascular ICUs. When the pandemic began, he was serving as senior medical director for critical care services as well as was interim director for ECMO services. Initially, Hatton's role focused on training and preparing the anesthesia critical care team to help provide care for non-COVID ICU patients, as much of the medicine ICU staff's time was spent caring for COVID-positive inpatients. ECMO, the highest form of life support, is a machine that takes over function of a patient's damaged heart and/or lungs by removing a patient's blood, oxygenating it, and returning it into the body. Though ECMO is used on a daily basis at UK HealthCare, its use skyrocketed during the pandemic as patients whose lungs were severely damaged by the virus needed this highest form of life support. As interim director for ECMO services, Hatton and his team had to rapidly develop protocols and processes to use the limited number of ECMO machines to help the most patients possible.   Ashley Montgomery-Yates, M.D., has been physician in the UK Division of Pulmonary, Critical Care and Sleep Medicine since 2013. As a critical care physician, she works primarily in the MICU setting taking care of the sickest patients – people on ventilators, with multi-organ failure, post-operative complications, and more. In 2013, she launched UK HealthCare's ICURecovery Clinic, which helps patients who have been in the ICU navigate the follow-up care and resources they need to recover. At the time, UK HealthCare's ICU Recovery Clinic was just one of three in the nation. Montgomery-Yates is currently the senior vice chair for the Department of Internal Medicine. When the pandemic began, she had recently become the interim chief medical officer for inpatient and emergency services. In this role and as an ICU physician, Montgomery-Yates and her colleagues were heavily involved in the day-to-day care of inpatients with COVID-19. She was part of the team that launched UK's successful Mass Vaccination Clinic out at Kroger Field, and her ICU teams also helped guide the creation of UK HealthCare's brand-new MICU, which opened January 2024.   Meg Pyper is a division charge nurse with the UK Albert B. Chandler Hospital Emergency Department and has been with UK HealthCare Emergency Medicine since 2010. As a charge nurse, her role is like air traffic control for the ED — taking calls from EMS and local hospitals about incoming patients and transfers, determining what services that patient will need upon arrival, and notifying interdisciplinary team members to be prepared when those patients arrive. As a nurse, she was drawn to emergency medicine after seeing her favorite nurse mentors be “the calm in the chaos.” Pyper began in this role just weeks before the pandemic arrived in Kentucky, and she and her team were the first line of care COVID patients received when they arrived at UK Chandler Hospital.   Lindsay Ragsdale, M.D., is the chief medical officer for Kentucky Children's Hospital and chief of the Division of Pediatric Palliative Care. Since arriving at UK in 2013, she has worked to build a robust program that helps seriously ill young patients and their families by caring for them holistically – looking at their physical, mental, emotional and spiritual well-being, and helping them navigate the experience of being severely ill.  Ragsdale became the KCH CMO in 2021, right when the COVID-19 delta variant was beginning to affect children much more than previous variants had. She helped set up both the pediatric monoclonal antibody clinic that provided infusions to help protect high-risk pediatric patients, as well as the successful pediatric vaccine clinic, which provided COVID-19 vaccines for children in a playful, engaging environment.   Rob Sprang is the director of Kentucky TeleCare, a role he's held at UK since 1996. UK first began using telehealth services in 1995. Since then, telehealth has grown by leaps and bounds, but its use skyrocketed during the pandemic. Earlier days of telehealth were usually done facility-to-facility — however, the vastly improved technology and public acceptance of telehealth, along with new, more relaxed regulatory laws around its use has allowed telehealth to explode in popularity. When the pandemic hit Kentucky, Sprang and his team — along with countless ambulatory providers and staff – worked 24/7 for more than a week to get UK HealthCare clinics set up to offer telehealth so that patients could still see their providers without needing to go into the hospital or clinic. Telehealth was a critical element in helping to protect both patients and providers from potential exposure to COVID-19.   Vince Venditto, Ph.D., is an associate professor of pharmaceutical sciences in the UK College of Pharmacy with a background in chemistry, drug delivery, and vaccine development. In the early days of the pandemic, his work in blood analysis – looking for biomarkers for cardiovascular disease in up to 1,500 samples at a time – was adapted to do mass testing for COVID antibodies as a means of diagnosis. After PCR tests became the gold standard for diagnosing the disease, his work shifted again — this time to working with local pharmacies for surveillance of COVID out in Kentucky communities. Post-COVID, this project has evolved to include other infectious diseases and inflammatory conditions, and it focuses on increasing access to health care through Kentucky's network of pharmacies. It also has a new name: Pharmacy-based Recruitment Opportunities To Enhance Community Testing and Surveillance (PROTECTS). Venditto co-directs this project along with Brooke Hudspeth, Pharm.D., an associate professor of pharmacy practice and science. Venditto is also part of The Consortium for Understanding and Reducing Infectious Diseases in Kentucky (CURE-KY), which fosters multidisciplinary collaborations to address the burden of infectious diseases in the Commonwealth and beyond. This consortium was built on the heels of UK's COVID-19 Unified Research Experts (CURE) Alliance, which was quickly assembled in 2020 to support a full range of COVID-related research. -- Behind the Blue is available via a variety of podcast providers, including iTunes and Spotify. Become a subscriber to receive new episodes of “Behind the Blue” each week. UK's latest medical breakthroughs, research, artists and writers will be featured, along with the most important news impacting the university. Behind the Blue is a joint production of the University of Kentucky and UK HealthCare. Transcripts for this or other episodes of Behind the Blue can be downloaded from the show's blog page.  To discover how the University of Kentucky is advancing our Commonwealth, click here.  

After 51 days of sedation and immobility in the ICU and on ECMO, Angela Leggett spent almost 2 decades battling post-ICU PTSD. She shares with us her journey and the impact of UCF Restores to give her a new chance at quality of life! UCF RestoresWww.DaytonICUConsulting.com

In this episode, we drop in on the Colorado ACEP Leadership Symposium with a talk by Dr. Chris Tems as he poses the question on whether ECMO is the future of EM cardiac arrest resuscitation.

In this episode, we start out with an RSI featuring intern Lauren Brown discussing obstructive sleep apnea and its anesthetic implications. Next, we talk to ECMO expert Mohsin Zaidi about resuscitation in the most challenging- and sometimes dramatic- circumstances.

“I was almost not here. In 2015, I was in a coma, on ECMO (life support). I was given last rites, my family told to let me go as doctors said they had done all they could. A prayer blanket was laid on me after my head was shaved and my brain scanned for activity. The prognosis? If I lived, I would probably be in a vegetative state, but that living probably would not happen as I had less than 1% chance of living.My CO2 level was over 200 (normal is 20-30). My blood was poison to myself. September 26 th, 2015 was one of my weekends to die. Family and friends came in from all over the world to continue prayers but realistically say “good-bye”. My daughter kept telling everyone I would live, which was treated as a faithful delusion.Now that I survived an unsurvivable situation, as a spiritual person, it inspired me to respect my body more and learn about our powerful bodies and spirit. This experience has strengthened my faith and has inspired me to pursue postgraduate studies, and complete a Doctoral degree in genetics and osteopathic medicine. I do believe we were created with the ability to heal or improve our bodies and overcome environmental issues which damage or change our DNA. I feel called to share my amazing story in order to help empower others spiritually and scientifically.I believe that when we all respect the earth and respect our bodies we have a winning symbiotic relationship.“God breathed life. The universe nourished. Man flourished.” - ELhttps://www.url1111.com/https://linktr.ee/lessthan1percent  https://www.pastliveshypnosis.co.uk/https://www.patreon.com/ourparanormalafterlife

Contributor: Aaron Lessen, MD Educational Pearls: Colchicine is most commonly used for the prevention and treatment of gout There is research investigating the anti-inflammatory and cardioprotective effects of colchicine  This drug has a narrow therapeutic index: a small margin between effective dose and toxic dose Colchicine overdoses can be unintentional or intentional and are associated with poor outcomes Phase 1: 10 - 24 hours after ingestion Patient looks well but may have mild symptoms mimicking gastroenteritis Phase 2: 24 hours - 7 days after ingestion Multiple organ dysfunction syndrome (MODS) Phase 3: recovery is usually within a few weeks of ingestion Treatment for colchicine overdose Treat early and aggressively Gastrointestinal decontamination with activated charcoal and orogastric lavage  Dialysis and ECMO for MODS treatment References Finkelstein Y, Aks SE, Hutson JR, Juurlink DN, Nguyen P, Dubnov-Raz G, Pollak U, Koren G, Bentur Y. Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila). 2010 Jun;48(5):407-14. doi: 10.3109/15563650.2010.495348. PMID: 20586571. Gasparyan AY, Ayvazyan L, Yessirkepov M, Kitas GD. Colchicine as an anti-inflammatory and cardioprotective agent. Expert Opin Drug Metab Toxicol. 2015;11(11):1781-94. doi: 10.1517/17425255.2015.1076391. Epub 2015 Aug 4. PMID: 26239119. Summarized by Meg Joyce, MS1 | Edited by Meg Joyce & Jorge Chalit, OMS3 Donate: https://emergencymedicalminute.org/donate/  

VOV1 - Hiện nay, số ca mắc cúm đang gia tăng ở nhiều nước trên Thế giới và tại Việt Nam, nhiều ca biến chứng nặng, phải nhập viện điều trị đặc biệt, thở máy ECMO. Sự gia tăng nhanh chóng của số ca mắc cúm, khiến các bệnh viện luôn trong tình trạng quá tải.

On this week's episode of Critical Care Time, we sit down with two brilliant early-career ECMOlogists for an “intro-plus” to VV and VA ECMO. Not only do we cover the basics, but we couldn't help ourselves and went on some deep dives along the way that you guys will hopefully find interesting! With the help of our good friends Nick Villalobos and Kha Dinh, we review indications for ECMO, approaches to configuration and management, touch on some of the complications and… even spend some time demystifying the European unit for girth! We hope you guys will have as much fun listening to this as we did producing it. If so, leave us a review and let us know what you think! Hosted on Acast. See acast.com/privacy for more information.

VOV1 - Bệnh viện Bệnh Nhiệt đới Trung ương cho biết, bệnh viện đang điều trị cho 8 bệnh nhân mắc cúm nhưng một số đã trở nặng, có bệnh nhân đã phải đặt ECMO. Bệnh cúm có thể trở nên nguy hiểm, dẫn đến tổn thương phổi lan tỏa, bội nhiễm vi khuẩn, viêm cơ tim, suy đang tạng và thậm chí tử vong.

This week, we continue our discussion with Dr Yusuff Hakeem, picking up where we left off. We're diving deeper into the complexities of intensive care, focusing specifically on the intricacies of Extracorporeal Membrane Oxygenation (ECMO) and patients experiencing renal failure. Tune in now for this crucial episode 

VOV1 - Chiều nay, Bệnh viện Bệnh Nhiệt đới Trung ương cho biết, đang điều trị cho 8 bệnh nhân mắc cúm nhưng một số đã trở nặng, có bệnh nhân đã phải đặt ECMO. Bệnh cúm có thể trở nên nguy hiểm, dẫn đến tổn thương phổi lan tỏa, bội nhiễm vi khuẩn, viêm cơ tim, suy đang tạng và thậm chí tử vong.

A pinkie promise is a promise you cannot break, and it's one our patient in this month's episode made to his wife when he was stricken with a life-threatening COVID infection. She made him promise that he would pull through the ordeal, and he did... but not without many bumps in the road.    Our team not only battled our patient's COVID, but also a nasty case of pneumonia that ultimately led to him needing to be placed on ECMO, which, as you know, is usually a last resort. Listen in as they transported him prone, which our team had never done before in 20+ years of experience, dealt with an unexpected hailstorm during transport and find out how our patient ended up doing after a lung transplant.   Interested in obtaining CE credit for this episode? Visit OnlineAscend.com to learn more. Listeners can purchase individual episode credits or subscribe to the Critical Care Review Bundle and gain access to all episode CE Credits.    We are joined by:     Jeff Dickson, NRP, FP-C     The Wilkins Family Click here to download this episode today! As always thanks for listening and fly safe! Hawnwan Moy MD FACEP FAEMS John Wilmas MD FACEP FAEMS Nyssa Hattaway, BA, BSN, RN, CEN, CPEN, CFRN

Welcome to our first episode recorded at the London Trauma Conference 2024. In this episode, hosts Iain Beardsell and Natalie May are joined by Matt Hooper from Adelaide to discuss his unique career path, from emergency medicine to pre-hospital and retrieval medicine, intensive care, and more recently, palliative and end-of-life care. The conversation centres around the principles of end-of-life care, particularly in acute and traumatic scenarios, and how these can be integrated with life-saving efforts. Key points include the challenges of shifting focus from survival to quality of death, the importance of recognizing and supporting witnesses and caregivers, and the concept of 'compassionate resuscitation.' Practical tools such as the 'pause' are also explored, aiming to humanize highly charged medical environments and potentially prevent burnout and PTSD among healthcare providers. 00:00 Introduction and Guest Welcome 01:00 Key Messages on Death and Palliative Care 02:12 Challenges in End-of-Life Care 03:20 Improving Quality of Death and Relationships 04:32 Emotional Impact on Care Providers 06:41 Navigating End-of-Life Conversations 12:17 Practical Applications in Intensive Care 16:41 The Pause: A Tool for Reflection 21:58 Conclusion and Final Thoughts The Guest - Matt Hooper Matt is an accomplished intensive care specialist with a diverse background in emergency medicine, prehospital & retrieval medicine, and palliative care. Notable for his leadership in developing critical care service models, he founded South Australia's MedSTAR Emergency Medical Retrieval Service. He has also co-authored a highly regarded case-based text book and held key teaching and examining roles nationally and internationally in prehospital and retrieval medicine. With a strong focus on high-performance teams working within high acuity, high consequence environments, Matt's expertise has also extended to human factors in healthcare, cardiothoracic intensive care, ECMO, and clinical ultrasound. More recently however, he has pivoted towards palliative and end of life care, pursuing a Master's degree at Cardiff University and consulting at Mary Potter Hospice in Adelaide. He is passionate about exploring new and innovative ways to prevent potentially avoidable suffering and enhance end of life outcomes for patients in acute care clinical environments.

If you thought ARDS was a long episode... get ready for a marathon! This week on Critical Care Time, Cyrus and Nick take on the unenviable task of trying to cover everything you need to know about cardiogenic shock - at least in broad strokes - in ONE episode! That's right, this is your one-stop-shop for all things cardiogenic shock. While we will have some deep dives on RV and LV failure, as well as ECMO and other mechanical circulatory support options - this episode has a little bit of it all to wet your whistle and then some! We deconstruct the epidemiology of cardiogenic shock, do a deep dive on the SCAI classes of cardiogenic shock, talk pathophysiology (duh!) and then move on to treatment considerations - both medical and mechanical - followed finally by some cases to cement all the learning. We know this is a long one so feel free to listen/watch in chunks. However you decide to enjoy it, we are certain you will walk away from it ready to conquer the next CGS case you come across! Once you've finished this epic - leave us a review and let us know how we did! Hosted on Acast. See acast.com/privacy for more information.

SHOW NOTES 2:25 – heart transplant at age 29, no previous cardiac issues3:00 – post-partum cardiomyopathy3:30 – placed on a Life Vest and a low ejection fraction4:30 – a 49-day stay in the hospital5:15 – the fear of leaving one's children behind, without a mom6:15 – emergency room, to a two-week stay, to “we've done all we can for you”7:00 – options and prognosis regarding Cassidy's heart8:30 – praying and deciding to move forward with a heart transplant9:45 – ECMO10:15 – shifting one's perspective during and after a heart transplant11:00 – Cassidy's mom, cardiomyopathy, and her heart transplant months after Cassidy's12:00 – the wait for a heart, and testing for the best match, for improved outcomes13:00 – antibodies after pregnancy can affect transplant success14:20 – a ten-hour surgery14:50 – the new heart needs to wake up16:00 – the importance of family and a support system17:30 –Dr. Allene Magill, an influential leader in education, and in Cassidy's life19:00 – Cassidy's decision to change her career path change21:00 – Shifting plans to find the “sweet spot” for one's work22:30 – teaching and learning, equal importance23:00 – organ donors changes lives and save lives25:00 – donor family and recipient interaction25:30 – a donor's organ can be classified as high-risk26:00 – How does life change when you have someone else's heart replace your own?27:15 – Piedmont Cartersville, Piedmont Atlanta, Samsky Heart Failure Clinic28:00 – great teachers…29:15 – Matt Fox, Becky Reynolds30:00 – Cassidy's closing comments LINKSCardiomyopathyECMOEjection FractionLifeVestTM - Cleveland Clinic pageLifeVestTM - Zoll pageLVADOrgan Donation - American Society of TransplantationOrgan Donation - Donate LifeOrgan Donation - UNOSPiedmont CartersvillePiedmont AtlantaSamsky Heart Failure CenterFairmount Elementary SchoolRed Bud Middle SchoolSonoraville High School   Music for Lead. Learn. Change. is Sweet Adrenaline by Delicate BeatsPodcast cover art is a view from Brunnkogel (mountaintop) over the mountains of the Salzkammergut in Austria, courtesy of photographer Simon Berger, published on www.unsplash.com.Professional Association of Georgia EducatorsDavid's LinkedIn pageLead. Learn. Change. the book

In this World Shared Practice Forum podcast, Dr. Dennis Daniel discusses pediatric extracorporeal life support (ECLS) with experts Drs. Peta Alexander and Ryan Barbaro. They explore the differences between pediatric and adult extracorporeal cardiopulmonary resuscitation (ECPR), highlighting differing causes of cardiac arrest and the interpretation of recently published studies. The discussion also covers supply chain issues affecting ECMO availability, the importance of standardized, evidence-based practices to identifying ECMO-associated complications, and opportunities for future research into ECMO use and outcomes. LEARNING OBJECTIVES - Identify the key differences between pediatric and adult extracorporeal cardiopulmonary resuscitation (ECPR), focusing on technical challenges and typical causes of cardiac arrest - Discuss the challenges facing standardization of pediatric ECMO care, including supply chain issues and approaches to capturing and classifying ECMO-associated complications - Describe areas of need and opportunity for future research in pediatric ECMO AUTHORS Peta Alexander, MBBS, FRACP, FCICM Senior Associate Cardiologist Director of ECMO Program Boston Children's Hospital Associate Professor in Pediatrics Harvard Medical School Ryan Barbaro, MD, MSc Service Chief of Pediatric Critical Care Medicine Director of Pediatric ECMO C.S. Mott Children's Hospital Clinical Associate Professor in Pediatric Critical Care University of Michigan Dennis Daniel, MD ECMO Medical Director, Medical-Surgical ICU Associate Director, OPENPediatrics Boston Children's Hospital DATE Initial publication date: January 27, 2025. ARTICLES REFERENCED AND ADDITIONAL RESOURCES - Alexander PMA, Di Nardo M, Combes A, et al. Definitions of adverse events associated with extracorporeal membrane oxygenation in children: results of n international Delphi process from the ECMO-CENTRAL ARC. Lancet Child Adolesc Health. 2024;8(10):773-780. https://pubmed.ncbi.nlm.nih.gov/39299748/ - UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. UK Collaborative ECMO Trail Group. Lancet. 1996;348(9020):75-82. https://pubmed.ncbi.nlm.nih.gov/8676720/ - Biomarkers of Brain Injury in Critically-Ill Children on Extracorporeal Membrane Oxygenation (ECMOhttps://reporter.nih.gov/project-details/10545733 - TITRE - Trial of Indication-based Transfusion of Red Blood Cells in ECMO, https://www.childrenshospital.org/clinical-trials/nct05405426 - ASCEND study: https://chear.org/our-research/projects/ascend-ards-children-and-ecmo-initiation-strategies-impact-neuro-development TRANSCRIPT https://cdn.bfldr.com/D6LGWP8S/at/bzpc2445cxrk9zch4wqvjjs5/012525_WSP_Updates_in_Pediatric_ECMO.pdf Please visit: http://www.openpediatrics.org OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children's Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open access, thus at no expense to the user. For further information on how to enroll, please email: openpediatrics@childrens.harvard.edu CITATION Alexander PMA, Barbaro RP, Daniel D. Updates in Pediatric ECMO: Challenges and Opportunities. 01/2025. OPENPediatrics. Online Podcast. https://soundcloud.com/openpediatrics/updates-in-pediatric-ecmo-challenges-and-opportunities-by-p-alexander-r-barbaro-openpediatrics.

Send us a Text Message (please include your email so we can respond!)Episode 56! In this episode we spend a few minutes talking about making decisions on ECMO initiation but spend most of the episode talking about ADAPT-Sepsis or "Biomarker-Guided Antibiotic Duration for Hospitalized PatientsWith Suspected Sepsis" published by Dark et al in JAMA 2024 and presented at the CCR Down Under Conference.ADAPT-Sepsis (pubmed): https://pubmed.ncbi.nlm.nih.gov/39652885/ADAPT-Sepsis (JAMA): https://jamanetwork.com/journals/jama/article-abstract/2828036If you enjoy the show be sure to like and subscribe, leave that 5 star review! Be sure to follow us on the social @icucast for the associated figures, comments, and other content not available in the audio format! Email us at icuedandtoddcast@gmail.com with any questions or suggestions! Thank you Mike Gannon for the intro and exit music!

Date: December 2o, 2024 Reference: Kotani et al. Positive single-center randomized trials and subsequent multicenter randomized trials in critically ill patients: a systematic review. Crit Care. 2023  Guest Skeptic: Dr. Scott Weingart is an ED Intensivist from New York. He did fellowships in Trauma, Surgical Critical Care, and ECMO. He is a physician coach concentrating […] The post SGEM#465: Not A Second Time – Single Center RCTs Fail To Replicate In Multi-Center RCTs first appeared on The Skeptics Guide to Emergency Medicine.

Niels Riedemann, the CEO, Founder, and Executive Director of the Board of InflaRx, explains that InflaRx develops pioneering anti-inflammatory therapeutics against a specific portion of the complement cascade, a part of the body's immune system that responds to infectious microbes. By applying its proprietary monoclonal anti-C5a and anti-C5aR technologies, InflaRx hopes to affect the progression of a wide variety of inflammatory diseases.  Niels explains, "Absolutely. So, I was a postdoc and research fellow at the University of Michigan and I researched this immune response I was talking about with another fellow in settings of sepsis of devastating, life-threatening inflammation and the other fellow and myself found it so intriguing that we ended up founding a company saying we're going to one day hopefully save people's lives with this approach by controlling this immune response. And when COVID came along, while we had a focus on other diseases and we have a key focus on devastating chronic diseases as well in the immune dermatological space and others, when COVID came along, we had all this knowledge and all this work in the immune response in life-threatening infections including in other viruses with our drug, for example, in an influenza type of virus. But we had not tested it, of course, in COVID or humans with this disease." "We felt we had to do something about it. We were very sure that this was a potential lifesaving approach. So we ended up running what we believe is the largest global study, a one-to-one randomized placebo-controlled study that was powered to show a benefit, a survival benefit, in the most severely sick COVID-patients. And when I say most severely sick, I really mean patients that need invasive mechanical ventilation or even lung replacement therapy, also called ECMO. So that's our focus, and we ended up showing a survival benefit. We may be talking about this a bit today, but it's an interesting story and a life endeavor. I should probably also mention that in order to better understand the other side of the research part, I became a physician, and I actually ran a large academic ICU in Germany for almost seven years, and also enrolled patients in trials. So, I know how it is as an intensive care physician to take care of patients when they're that devastatingly sick. The lots of motivations within the company, and we are really glad that we could bring this drug forward to help patients." InflaRx.de Download the transcript here  

Niels Riedemann, the CEO, Founder, and Executive Director of the Board of InflaRx, explains that InflaRx develops pioneering anti-inflammatory therapeutics against a specific portion of the complement cascade, a part of the body's immune system that responds to infectious microbes. By applying its proprietary monoclonal anti-C5a and anti-C5aR technologies, InflaRx hopes to affect the progression of a wide variety of inflammatory  diseases.  Niels explains, "Absolutely. So, I was a postdoc and research fellow at the University of Michigan and I researched this immune response I was talking about with another fellow in settings of sepsis of devastating, life-threatening inflammation and the other fellow and myself found it so intriguing that we ended up founding a company saying we're going to one day hopefully save people's lives with this approach by controlling this immune response. And when COVID came along, while we had a focus on other diseases and we have a key focus on devastating chronic diseases as well in the immune dermatological space and others, when COVID came along, we had all this knowledge and all this work in the immune response in life-threatening infections including in other viruses with our drug, for example, in an influenza type of virus. But we had not tested it, of course, in COVID or humans with this disease." "We felt we had to do something about it. We were very sure that this was a potential lifesaving approach. So we ended up running what we believe is the largest global study, a one-to-one randomized placebo-controlled study that was powered to show a benefit, a survival benefit, in the most severely sick COVID-patients. And when I say most severely sick, I really mean patients that need invasive mechanical ventilation or even lung replacement therapy, also called ECMO. So that's our focus, and we ended up showing a survival benefit. We may be talking about this a bit today, but it's an interesting story and a life endeavor. I should probably also mention that in order to better understand the other side of the research part, I became a physician, and I actually ran a large academic ICU in Germany for almost seven years, and also enrolled patients in trials. So, I know how it is as an intensive care physician to take care of patients when they're that devastatingly sick. The lots of motivations within the company, and we are really glad that we could bring this drug forward to help patients." InflaRx.de Listen to the podcast here    

Send us a Text Message (please include your email so we can respond!)Episode 55 and Happy New Year! In this episode we talk broad strokes about the CCR Down Under Conference and the trials that were presented, then Todd and Eddie go over a bunch of articles from the year 2024 that they didn't have time to go over or want to re-emphasize for whatever reason. Big show and we hope you enjoy!TIGHT K: https://pubmed.ncbi.nlm.nih.gov/39215972/PROPHY VAP: https://pubmed.ncbi.nlm.nih.gov/38262428/REVISE: https://pubmed.ncbi.nlm.nih.gov/38875111/Point (withdrawal of ECMO): https://pubmed.ncbi.nlm.nih.gov/39663030/Counterpoint: https://pubmed.ncbi.nlm.nih.gov/39663031/DanGer SHOCK: https://pubmed.ncbi.nlm.nih.gov/38587239/Intubation in physiologic difficult airway guidelines: https://pubmed.ncbi.nlm.nih.gov/39162823/If you enjoy the show be sure to like and subscribe, leave that 5 star review! Be sure to follow us on the social @icucast for the associated figures, comments, and other content not available in the audio format! Email us at icuedandtoddcast@gmail.com with any questions or suggestions! Thank you Mike Gannon for the intro and exit music!

In this special holiday bonus episode, Ryan takes a look back at some of the most captivating episodes of The Poison Lab from 2022. Get ready for an ultimate test of your toxicology differential diagnosis skills as we compile all the "Stump the Toxicologist" segments into one streamlined, binge-worthy episode. Explore eight unique poisoning cases, be sure to check the show notes for a description of each case. time stamp of where it begins, and links to the original episodes, where you can dive deeper into the discussions and unravel the mysteries behind these intriguing cases! Case Teasers and Time StampsEpisode 13, March 2nd, 2022: Dr. Howard Greller0:06:19 Case 1: A 19-year-old male collapses at home and presents to the ED unresponsive, tachycardic, and hypotensive, with a wide QRS complex on EKG and a serum lactate of 20. 0:22:58 Case 2: A 16-year-old female presents to the ED 9 hours after ingesting 100 tablets of an unknown medication in a suicide attempt. She presents with vomiting, lethargy, bloody diarrhea, and a metabolic acidosis. An abdominal x-ray shows numerous radiopaque tablets in her GI tract. She is treated with a redacted antidote and whole bowel irrigation, but her condition worsens and she develops liver failure. She is transferred to a tertiary care center for a liver transplant, but recovers. On day 12, she develops a lower GI bleed and bowel perforation and dies. 0:34:42 Case 3: A seven-month-old child presents with crying, cough, vomiting, and respiratory distress. 0:37:42 Case 4: A 32-year-old male with a history of alcohol use and depression presents to the ED seven hours after ingesting two handfuls of an unknown medication and alcohol in a suicide attempt. He is initially anxious and tremulous, but has normal vital signs and labs, aside from an elevated ethanol level. He has a seizure nine hours after ingestion. His EKG shows a widened QRS, and he becomes hypotensive. He is intubated, placed on vasopressors, and undergoes extracorporeal membrane oxygenation (ECMO) and targeted temperature management (TTM), but dies three days later. Episode 15, July 6th, 2022: Dr. Josh Trebach0:46:11 Case 1: Two British medical students present to the ED after developing nausea, vomiting, paresthesias, myalgias, pruritus, and cold allodynia 12 hours after sharing a meal. Their neurological symptoms persisted for 4 weeks and the cold allodynia for 10 weeks.0:54:18 - 1:05:23 Case 2: A 16-year-old female presents to the ED unresponsive and cyanotic after intentionally ingesting a substance purchased online. Her oxygen saturation is in the 70s and a methemoglobin level is greater than 30%. 1:05:25 - 1:10:18 Case 3: A 48-year-old female, and co-author of the published case report, presents to the ED 10 minutes after eating a “peppery” tuna steak. She is tachycardic, hypotensive, flushed, and has conjunctival erythema. She also experiences abdominal pain, nausea, vomiting, diarrhea, headache, and chest pain. Her EKG shows tachycardia with ST depression. She requires phenylephrine to maintain her blood pressure. She is treated with famotidine and discharged from the hospital 43 hours later. 1:10:20 – 1:13:16 Case 4: A 63-year-old female presents to the ED 12 hours after ingesting five capsules of a weight loss product. She is bradycardic and has nausea, vomiting, and hyperkalemia.Episode 17, November 9th, 2022: Dr. Emily Kieran1:16:35 Case 1: A 34-year-old female presents to a clinic in West Bengal, India, with a three-year history of skin changes. She has hypo-pigmented macules on a background of hyperpigmentation, creating a “raindrop” like appearance on her...

Send us a textIn this conversation, Dr. Kyle Willse, a pediatric intensivist, shares insights on the Pediatric Intensive Care Unit (PICU).  The discussion is meant to provide a basic understanding as to how the  PICU operates and to help parents be an advocate for their children.   A must listen for anybody who has a child or a loved one in the PICU.Kyle Willse, DO, is board certified in Pediatrics and in Pediatric Critical Care.  For the past 5 years, he has worked at Cedars-Sinai hospital as an attending in the pediatric and congenital cardiac intensive care unit.  His comments in the podcast are his individual thoughts and opinions and do not represent Cedars Sinai.    Dr Jessica Hochman is a board certified pediatrician, mom to three children, and she is very passionate about the health and well being of children. Most of her educational videos are targeted towards general pediatric topics and presented in an easy to understand manner. For more content from Dr Jessica Hochman:Instagram: @AskDrJessicaYouTube channel: Ask Dr JessicaWebsite: www.askdrjessicamd.com-For a plant-based, USDA Organic certified vitamin supplement, check out : Llama Naturals Vitamin and use discount code: DRJESSICA20-To test your child's microbiome and get recommendations, check out: Tiny Health using code: DRJESSICA Do you have a future topic you'd like Dr Jessica Hochman to discuss? Email Dr Jessica Hochman askdrjessicamd@gmail.com.The information presented in Ask Dr Jessica is for general educational purposes only. She does not diagnose medical conditions or formulate treatment plans for specific individuals. If you have a concern about your child's health, be sure to call your child's health care provider.

In this episode of the St Emlyn's podcast, hosts Iain Beardsell and Liz Crowe are joined by Chris Bishop, a clinical research fellow at the Centre for Trauma Sciences at Queen Mary University of London. Chris discusses his PhD research on veno-arterial ECMO support for cardiogenic shock following major trauma haemorrhage and explains the principles and applications of ECMO, particularly in trauma patients. The conversation covers the current practices, challenges, and future directions in the use of ECMO for trauma care, including multidisciplinary decision-making, patient selection criteria, and pioneering techniques like selective aortic arch perfusion and emergency preservation and resuscitation. 00:00 Introduction 01:12 Understanding ECMO and Its Applications 02:20 ECMO in Trauma Patients 04:17 Challenges and Resistance in ECMO Adoption 05:36 Current Research and Practices 11:31 Future Directions in Trauma Resuscitation 13:28 Conclusion

CHEST December 2024, Volume 166, Issue 6 Elias H. Pratt, MD, joins CHEST® Journal Podcast Moderator Alice de Gallo Moraes, MD, to discuss his research exploring whether implementation of different institutional RBC transfusion thresholds for patients receiving venovenous ECMO is associated with changes in RBC use and patient outcomes. DOI: 10.1016/j.chest.2024.05.043   Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers' opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.

Welcome to today's episode of This Thing Called Life, where we delve into the ever-evolving care plan of organ, eye, and tissue donation. In this episode, we're joined by Andi Johnson and Dr. Jordan Bonomo to explore a key recommendation from the 2021 National Academies of Sciences, Engineering, and Medicine (NASEM) report aimed at transforming organ donation and transplantation practices to create a more equitable system. Dr. Bonomo shares insights into a groundbreaking initiative—the establishment of a donor care unit within UCMC's new Flex ICU. This innovative, first-of-its-kind model is designed to improve organ donation outcomes by providing comprehensive, compassionate care to both donors and their families. Tune in for this important conversation on enhancing the donor experience and advancing the future of organ donation.   Episode Highlights: Introducing Dr. Jordan Bonomo. He is a physician at the University of Cincinnati Medical Center. He's the Medical Director of the flex ICU and a professor of Emergency Medicine, neurology, neurosurgery, and neurocritical care. He is also the attending physician for anesthesia, critical care, and ECMO, and he's the medical director for donor management, for Network For Hope, formerly Life Center.  Dr. Bonomo explains the long-term development of the Flex ICU, emphasizing its multifaceted purpose to serve critically ill patients and enhance organ donation capacity. The Flex ICU aims to provide specialized care for organ donors, improving the yield and survival rate of donated organs. Specialized units can focus on the needs of the donor from a physiological standpoint and the needs of the family from an emotional standpoint. This aims to provide a much more synchronized environment and holistic care for the families and adhere to the donor wishes. All the staff are fully trained and they're vetted and vested at the same time in the process of donation.  The purpose is to have the best donor care unit available anywhere in the country. The unit is staffed 24/7 by dedicated teams to support the mission of Network for Hope. The unit is limited to donors who have been declared dead by neurologic criteria. Note that in the month of October, the first month of the launch of Flex ICU, there were zero patients declared brain dead in the region. Dr. Bonomo explains the intentional design of the unit to accommodate donor families, offering them the option to be with their loved ones or to step back as needed. The Flex ICU aims to respect the wishes of donors and families, facilitating their involvement in the donation process. Dr. Bonomo discusses the potential impact of the Flex ICU on organ donation The goal is to optimize the process for donors, families, and organ recipients, balancing the need for timely transplantation with the potential for increased donation. Andi adds that the DCU, which is housed within the flex ICU, has been discussed as a key part of the flex ICU with providers, nurses, and physicians who will be working in this unit. The team is committed to doing right by donors, recognizing the privilege and obligation that comes with their role. The Flex ICU has attracted dedicated professionals who are passionate about improving organ donation and transplantation. The process of establishing the unit has been lengthy, involving multiple stakeholders and legal considerations.  He shares that this is an organ procurement organization initiative that really is somewhat independent of the healthcare system. The belief that donation can bring healing and good from tragedy has been a driving force for Dr. Bonomo.  Dr. Bonomo has a strong foundation in bioethics, having earned his undergraduate degree in the field. Throughout his career, organ donation has been a central focus of his work in biomedical ethics. Dr. Bonomo invites listeners to ask questions and seek education about the organ donation process. The importance of accurate information and understanding the process is important for effective collaboration and support. 3 Key Points:   Dr. Bonomo explains the long-term development of the Flex ICU, emphasizing its multifaceted purpose to serve critically ill patients and enhance organ donation capacity. The Flex ICU aims to provide specialized care for organ donors, improving the yield and survival rate of donated organs. The unit is limited to donors who have been declared dead by neurologic criteria. So brain dead donors, and brain dead vernacular term death by neurologic criteria. Dr. Bonomo explains the intentional design of the unit to accommodate donor families, offering them the option to be with their loved ones or to step back as needed. The Flex ICU has attracted dedicated professionals who are passionate about improving organ donation and transplantation. The team is committed to doing right by donors, recognizing the privilege and obligation that comes with their role.   Tweetable Quotes: “Dr shutter explained to me that we do our best to save them, but when you can't, your obligation doesn't end, and the opportunity to donate is an absolute good when done well…” - Dr. Bonomo “So the the flex ICU has been in design and development for a really long time, I mean, north of 15 years, and we've had fits and starts, and we finally were able to construct it…” - Dr. Bonomo “We have teams that are dedicated to supporting the mission and network for hope, formerly Life Center…” - Dr. Bonomo “I think every family is interested in knowing that their loved one is well cared for and that their wishes are being respected.” - Dr. Bonomo Resources: https://getoffthelist.org/ https://www.networkforhope.org/ https://www.networkforhope.org/about-us/ https://www.facebook.com/NetworkForHopeOPO https://www.youtube.com/@NetworkforHope. https://aopo.org/

      Can a career in military medicine offer unexpected opportunities to innovate and shape the future of healthcare? Join us as we explore this intriguing question with Air Force Neurologist Lieutenant Colonel Adam Willis, MD. From his initial fascination with physics to his pivotal role in supporting operational medicine, Adam recounts his unique journey and the moment that brain-computer interface technology ignited his passion for neurology. Discover how neurologists make crucial contributions in managing traumatic brain injuries and seizures in combat zones while addressing the longer-term challenges of headaches, sleep disruptions, and cognitive performance.     In this episode, we unravel the complexities of trauma patient evacuation and the innovative strides being made to enhance survival rates. Adam sheds light on the "golden hour" concept and the development of groundbreaking technologies that ensure rapid access to care. As an insider at DARPA through the Service Chiefs Fellowship Program, Adam shares how his experiences have spurred projects to revolutionize field intensive care medicine. Learn about his work on a game-changing intravascular cannula project, which promises to transform medical care from the injury site through evacuation.     Finally, dive into the world of DARPA with insights into projects like SNAP, which seeks to assess warfighters' readiness using non-invasive biomarkers. Adam's story serves as a reminder of the power of commitment and proactivity in military medicine careers. Individuals can unlock doors to additional training and career advancement by aligning personal goals with the organization's mission. Hear how seizing unexpected opportunities and embracing new challenges can lead to meaningful contributions to the future of military medicine.   Chapters: (00:04) Neurology in Military Medicine (15:39) Advances in Trauma Patient Evacuation (23:16) Revolutionizing Field Intensive Care Medicine (28:01) Innovating Military Technology With DARPA (40:48) Commitment and Innovation in Military Medicine   Chapter Summaries: (00:04) Neurology in Military Medicine    Air Force neurologist discusses role in military medicine, managing TBI and seizures, and innovative intravascular cannula for polytrauma patients. (15:39) Advances in Trauma Patient Evacuation   Maximizing survival from traumatic injuries through rapid patient movement and exploring innovative projects at DARPA. (23:16) Revolutionizing Field Intensive Care Medicine    Collaboration between DARPA and industry to develop a miniaturized, non-anticoagulated ECMO-like system for extending the golden hour in emergency medical situations. (28:01) Innovating Military Technology With DARPA     DARPA program manager crafts questions to harness innovation, funded by DoD, SNAP project for non-invasive warfighter readiness assessment. (40:48) Commitment and Innovation in Military Medicine     Commitment and proactivity in military medicine careers can lead to opportunities for training and advancement.   Take Home Messages: Career Flexibility and Innovation: The journey from a physics background to a career in military neurology demonstrates the importance of being open to unexpected career paths. Embracing new technologies, such as brain-computer interfaces, can lead to groundbreaking roles in fields like military medicine. Neurology's Critical Role in Combat Medicine: Neurologists play a vital role in managing traumatic brain injuries and seizures in combat situations. Their expertise extends beyond acute care, addressing post-TBI issues like headaches and cognitive disruptions, which are essential for maintaining operational readiness. Advancements in Trauma Evacuation: Innovations in trauma care, such as extending the "golden hour," are crucial for improving survival rates from traumatic injuries. Technologies that facilitate rapid and scalable patient movement to definitive care can significantly impact outcomes. Integration of Technology and Medicine: The collaboration between military medicine and advanced research agencies, like DARPA, showcases the potential of integrating artificial intelligence and biotechnology to revolutionize trauma care. Projects like SNAP, which use non-invasive biomarkers, highlight the future of assessing warfighter readiness. Importance of Commitment and Networking: Aligning personal ambitions with organizational missions, seizing opportunities, and proactive networking are key strategies for career advancement in military medicine. Taking initiative and being open to new challenges can lead to significant contributions in the field.   Episode Keywords: Military Medicine, Combat Neurology, Brain-Computer Interface, Traumatic Brain Injury, Battlefield Innovation, DARPA, Adam Willis, Trauma Care, Intravascular Cannula, SNAP Initiative, Artificial Intelligence, Biotechnology, Military Healthcare, Neurocritical Care, Trauma Patient Evacuation, Field Intensive Care, Military Technology, Warfighter Readiness Hashtags: #MilitaryMedicine #CombatNeurology #BattlefieldInnovation #BrainInjuryCare #DARPA #TraumaCareTech #NeuroInnovation #OperationalMedicine #MilitaryHealthcare #WarfighterReadiness   Honoring the Legacy and Preserving the History of Military Medicine The WarDocs Mission is to honor the legacy, preserve the oral history, and showcase career opportunities, unique expeditionary experiences, and achievements of Military Medicine. We foster patriotism and pride in Who we are, What we do, and, most importantly, How we serve Our Patients, the DoD, and Our Nation.   Find out more and join Team WarDocs at https://www.wardocspodcast.com/ Check our list of previous guest episodes at https://www.wardocspodcast.com/our-guests Subscribe and Like our Videos on our YouTube Channel: https://www.youtube.com/@wardocspodcast Listen to the “What We Are For” Episode 47. https://bit.ly/3r87Afm WarDocs- The Military Medicine Podcast is a Non-Profit, Tax-exempt-501(c)(3) Veteran Run Organization run by volunteers. All donations are tax-deductible and go to honoring and preserving the history, experiences, successes, and lessons learned in Military Medicine. A tax receipt will be sent to you. WARDOCS documents the experiences, contributions, and innovations of all military medicine Services, ranks, and Corps who are affectionately called "Docs" as a sign of respect, trust, and confidence on and off the battlefield,demonstrating dedication to the medical care of fellow comrades in arms.     Follow Us on Social Media Twitter: @wardocspodcast Facebook: WarDocs Podcast Instagram: @wardocspodcast LinkedIn: WarDocs-The Military Medicine Podcast YouTube Channel: https://www.youtube.com/@wardocspodcast

Extracorporeal membrane oxygenation, or ECMO, can be a lifesaving technology for patients whose organs have failed. It works, essentially, by performing the functions that a healthy person's lungs and heart would normally do. While using the machine, many recipients of ECMO treatment can walk, talk, even ride a stationary bike, but they can't leave the hospital with the machine, nor can they survive without it. In a recent article in The New Yorker, emergency physician and writer Clayton Dalton described these patients as “caught on a bridge to nowhere.” Marketplace's Lily Jamali spoke to Dalton about the complicated ethics of this technology.